Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

HER2 Enriched Subtype Breast Cancer, Herzuma, PAM50 Study

Tundra lists 1 HER2 Enriched Subtype Breast Cancer, Herzuma, PAM50 Study clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT04817540

Phase II Trial of Anti-HER2 Treatment in HER2-enriched Early Breast Cancer Identified by PAM50 (HER2E-PAM, PAMILIA Study)

In this study, we prospectively analyzed molecular subtyping through the PAM 50 test in HER2-negative (IHC1+ or 2+ (FISH/SISH-)) breast cancer patients. A phase 2 single arm study was designed to determine whether the addition of HER2-targeted treatment with treatment increases the pathologic remission rate.

Gender: All

Ages: 19 Years - Any

Updated: 2023-10-11

HER2 Enriched Subtype Breast Cancer, Herzuma, PAM50 Study